Angeles Wealth Management LLC Boosts Stake in HCA Healthcare, Inc. (NYSE:HCA)

Angeles Wealth Management LLC raised its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 7.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 808 shares of the company’s stock after purchasing an additional 53 shares during the period. Angeles Wealth Management LLC’s holdings in HCA Healthcare were worth $243,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare during the third quarter worth about $39,000. Capital Performance Advisors LLP acquired a new stake in shares of HCA Healthcare during the 3rd quarter valued at approximately $41,000. Canoe Financial LP bought a new stake in HCA Healthcare during the third quarter valued at $41,000. Northwest Investment Counselors LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at about $44,000. Finally, Friedenthal Financial acquired a new position in HCA Healthcare in the third quarter valued at approximately $50,000. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on HCA. Truist Financial reduced their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. KeyCorp decreased their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Oppenheimer increased their price objective on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a report on Monday, October 28th. Wells Fargo & Company cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price target for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Finally, TD Cowen lowered their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $385.67.

HCA Healthcare Trading Down 1.2 %

NYSE:HCA opened at $318.28 on Tuesday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The firm has a market capitalization of $80.62 billion, a price-to-earnings ratio of 14.49, a price-to-earnings-growth ratio of 1.11 and a beta of 1.64. The stock has a fifty day simple moving average of $313.75 and a 200 day simple moving average of $353.51.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the business posted $5.90 EPS. Sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.90%. The ex-dividend date of this dividend is Monday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is currently 12.02%.

Insider Activity

In other news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.